#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Meningococcal immunisation Neurodermatitis Li-Fraumeni syndrome Anti-HLA antibody test positive Infantile apnoea Congenital leptin deficiency Breast cancer Acute myeloid leukaemia (in remission) Testicular leiomyosarcoma Leber's congenital amaurosis Neuroblastoma recurrent Hodgkin's disease refractory Infection in an immunocompromised host Gestational trophoblastic tumour Synovitis More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Diagnostics Factor IX deficiency – Diagnostics Burkitt’s lymphoma Mantle cell lymphoma refractory – Basic Information Myelodysplastic syndrome – Life with Disease Angelman’s syndrome – Treatment KBG syndrome – Diagnostics Tuberous sclerosis complex – Basic Information Osteosarcoma – Basic Information Pemphigus More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Apotransferrin Cilazapril ZOREVUNERSEN SODIUM GS-4321 Gsk3739937 Tabelecleucel Cobimetinib Apraglutide Canakinumab S230815-2 Eplerenone AUROCELL-TX Reparixin Lenacapavir YOHIMBINE HYDROCHLORIDE SKB410 Agrostis Stolonifera Pollen Ucp2 Fluticasone ARFOLITIXORIN More therapies…

    Learn about Your Condition

    Peripheral artery restenosis Crigler-Najjar syndrome Hypomagnesaemia Thrombocytosis Skin neoplasm excision Triple positive breast cancer Astrocytoma malignant Vomiting Exposure via breast milk Sickle cell anaemia Kawasaki's disease Hyperthyroidism Type 1 diabetes mellitus Habitual abortion Testicular germ cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Posaconazole for Preventing Fungal Infections in Patients Receiving Stem Cell Transplants for Blood Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Posaconazole
    France

  • Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute leukaemia
    Investigated Drugs:
    • N-Ethyl-2-[4-[7-[[4-(Ethylsulfonylamino)Cyclohexyl]Methyl]-2,7-Diazaspiro[3.5]Nonan-2-Yl]Pyrimidin-5-Yl]Oxy-5-Fluoro-N-Propan-2-Ylbenzamide
    • Revumenib
    France Germany Italy Lithuania The Netherlands Spain

  • Study on Long-Term Safety of AAVAnc80-hOTOF Gene Therapy for Patients with Sensorineural Hearing Loss Due to Otoferlin Gene Mutations

    Recruiting

    4 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Aavanc80-3’Hotof
    • Aavanc80-5’Hotof
    Spain

  • Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Prilocaine
    • Lidocaine
    • Lidocaine Hydrochloride
    Spain

  • Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Eik1003
    • Abiraterone
    • Carboplatin
    Denmark France Spain

  • Study on Oxytocin and Self-Compassion Training for Patients with Borderline Personality Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Borderline personality disorder
    Investigated Drugs:
    • Oxytocin
    Spain
Previous Page
1 … 320 321 322 323 324 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!